Results 1 to 10 of about 22,236,668 (323)
Some of the next articles are maybe not open access.

Hyperbaric Oxygen Therapy for Chronic Radiotherapy-Related Adverse Effects: A Clinically Focused Review

Ca-A Cancer Journal for Clinicians
Lukas Käsmann   +2 more
exaly  

Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management

Ca-A Cancer Journal for Clinicians, 2016
Carmen Criscitiello   +2 more
exaly  

Emergency Hospitalizations for Adverse Drug Events in Older Americans

New England Journal of Medicine, 2011
Nadine Shehab, Daniel S Budnitz
exaly  

Clinical and translational attributes of immune-related adverse events

Nature Cancer
K. Suijkerbuijk   +3 more
semanticscholar   +1 more source

Racial disparities in breast cancer treatment patterns and treatment related adverse events [PDF]

open access: yesScientific Reports, 2023
The main objective of this work was to perform a comprehensive analysis and provide a race-stratified epidemiological report accounting for differences in treatment patterns and treatment related adverse events in Non-Hispanic women with breast cancer ...
Nickolas Stabellini   +7 more
doaj   +5 more sources

Miscarriage treatment‐related adverse events: A nationwide registry study from Finland [PDF]

open access: yesActa Obstetricia et Gynecologica Scandinavica
Introduction The treatment of miscarriage has transformed substantially from surgical to non‐surgical. The aim of this study was to evaluate the rates of adverse events related to the treatment of miscarriage and their risk factors.
Nea Helle   +5 more
doaj   +8 more sources

Treatment-related adverse events of antibody drug-conjugates in clinical trials [PDF]

open access: yesJournal of Hematology & Oncology
Background Antibody–drug conjugates (ADCs) aim to enhance the therapeutic index of cytotoxic agents but can cause unexpected toxicities. This study evaluated adverse events (AEs) from phase 1 trials at The Royal Marsden Drug Development Unit (DDU) over a
Harold Nathan Tan   +8 more
doaj   +5 more sources

Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice [PDF]

open access: yesFrontiers in Oncology, 2021
Bruton tyrosine kinase (BTK) inhibitors represent an important therapeutic advancement for B cell malignancies. Ibrutinib, the first-in-class BTK inhibitor, is approved by the US FDA to treat patients with chronic lymphocytic leukemia (CLL)/small ...
Susan M. O’Brien   +6 more
doaj   +9 more sources

Home - About - Disclaimer - Privacy